Discovery of a Thermostable Nigerose Phosphorylase for the Efficient Chemoenzymatic Radiosynthesis of a <i>S. aureus</i> –Targeted <sup>18</sup> F-Disaccharide
<i>Staphylococcus aureus</i> is a leading cause of life-threatening infections worldwide. The diagnosis and treatment of <i>S. aureus</i> infections are further complicated by the global rise of antimicrobial resistance. Therefore, rapid detection of active <i>S. aureus</i> remains a critical unmet need to provide effective infection management. In this study, we identified 2-deoxy-2-[<sup>18</sup>F]-fluorosakebiose ([<sup>18</sup>F]FSK) as an optimal radiotracer to detect active <i>S. aureus</i> and established its efficient chemoenzymatic radiosynthesis to facilitate clinical translation. <b>Methods</b>: Several [<sup>18</sup>F]FDG-derived disaccharides were obtained via reverse phosphorolysis: [<sup>18</sup>F]FSK (α-1,3–linked), 2-deoxy-[<sup>18</sup>F]-fluoromaltose (α-1,4–linked), 2-deoxy-2-[<sup>18</sup>F]-fluorolaminaribiose (β-1,3–linked), and 2-deoxy-2-[<sup>18</sup>F]-fluorocellobiose (β-1,4–linked). These tracers were screened in vitro in multiple <i>S. aureus</i> isolates to identify bacterial incorporation. The lead candidate, [<sup>18</sup>F]FSK, was further characterized via biodistribution and dosimetry analyses and evaluated in a <i>S. aureus</i> myositis model to assess antimicrobial treatment response. Finally, to promote the clinical translation of [<sup>18</sup>F]FSK, 2 different radiosynthetic strategies were investigated: reverse phosphorolysis of [<sup>18</sup>F]FDG using maltose phosphorylase and using newly identified nigerose (also called sakebiose) phosphorylases. <b>Results</b>: Nigerose phosphorylase–derived [<sup>18</sup>F]FSK was selected as the optimal radiotracer for detecting <i>S. aureus</i> because of its consistent and robust uptake in multiple <i>S. aureus</i> isolates. [<sup>18</sup>F]FSK demonstrated favorable distribution and elimination over time, with minimal nonspecific signals in uninfected organs. The estimated human effective doses indicated an effective dose comparable to that of [<sup>18</sup>F]FDG. The radiosynthesis of [<sup>18</sup>F]FSK, initially obtained as an accidental byproduct of maltose phosphorylase catalysis, was further improved using a nigerose phosphorylase originating from thermostable <i>Spirochaeta thermophila</i>, enabling nearly quantitative conversion of [<sup>18</sup>F]FDG to [<sup>18</sup>F]FSK (up to 97%). <b>Conclusion</b>: We demonstrated that [<sup>18</sup>F]FSK is a potent and robust PET radiotracer for the detection of active <i>S. aureus</i> in vivo and aids in the selection of an appropriate antimicrobial treatment. These findings highlight the potential use of [<sup>18</sup>F]FSK in promoting the effective management of <i>S. aureus</i> infections in clinical settings.
Authors
- Tom Desmet (ORCID: https://orcid.org/0000-0002-5788-3022)
- Jaelim Kim (ORCID: https://orcid.org/0000-0002-0432-2432)
- Giuseppe Felice Mangiatordi (ORCID: https://orcid.org/0000-0003-4042-2841)
- Shari Dhaene (ORCID: https://orcid.org/0000-0003-0887-7651)
- Kiel D. Neumann (ORCID: https://orcid.org/0000-0001-9093-3522)
- Adolfo Ancona
- David M. Wilson
- Engel Jc
- Youngho Seo (ORCID: https://orcid.org/0000-0001-5908-6636)
- Jung Min Kim (ORCID: https://orcid.org/0009-0003-9492-510X)
- Sang‐Hee Lee (ORCID: https://orcid.org/0000-0001-8578-9968)
- Marina López-Álvarez
- Robert R. Flavell
- Michael A. Ohliger (ORCID: https://orcid.org/0000-0001-6878-8189)
- Joseph Blecha (ORCID: https://orcid.org/0009-0009-2874-8479)
- Bernd Nidetky
- Eunsung Lee
- Wenxing Zou
- Alexandre M. Sorlin
Institutions
- University of Siena (IT)
- Pohang University of Science and Technology (KR)
- HOGENT University of Applied Sciences and Arts (BE)
- San Francisco General Hospital (US)
- St. Jude Children's Research Hospital (US)
- Seoul National University (KR)
- Seoul National University of Education (KR)
- University of California, San Francisco (US)
- New Generation University College (ET)
- Ghent University (BE)
- Graz University of Technology (AT)
- BioTechMed-Graz (AT)
- Institute of Crystallography (IT)
- UCSF Helen Diller Family Comprehensive Cancer Center (US)
- University of California, Berkeley (US)
Publication Details
- Journal
- Journal of Nuclear Medicine
- Published
- 2026-06-25
- DOI
- https://doi.org/10.2967/jnumed.125.271829
- Primary Topic
- Peptidase Inhibition and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 0.00